INS and metabolic disease: In the context of metabolic disease, sustained oxidative distress has been shown to impair GLUT4 translocation and dysregulate downstream effectors, highlighting the dual role of ROS as both facilitators and inhibitors of insulin action depending on concentration, duration, and cellular context [101,102,103,104].